Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.
Oncologist
; 28(7): e534-e541, 2023 07 05.
Article
in En
| MEDLINE
| ID: mdl-37120151
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Year:
2023
Type:
Article